GlassScriptPhysician profile
Mary B Garber
NPI 1831879592
$1,080.72
in general payments reported to CMS, 2019-2025
9 companies · $173 in 2025
The $173 reported for 2025 was less than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $226 · 2024: $682 · 2025: $173.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $978 · Entertainment: $102.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $978.41 |
| Entertainment | $102.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $229.47 | 2023-2025 | Total30, Precision 1, Dailies Total1 |
| Johnson & Johnson Surgical Vision, INC. | $196.18 | 2024-2025 | Catalys System, Tecnis Simplicity |
| Johnson & Johnson Vision Care, INC. | $181.09 | 2024 | Acuvue |
| Dompe US, INC. | $119.91 | 2024 | Oxervate |
| Optos, INC. | $102.31 | 2023 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Glaukos Corporation | $80.85 | 2023 | |
| Astellas Pharma US INC | $75.84 | 2024 | Izervay |
| Bausch & Lomb Americas INC. | $68.55 | 2023-2025 | Infuse |
| Mallinckrodt Hospital Products INC. | $26.52 | 2025 | Acthar |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mary Garber listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.